By Amber Smith Due to increasingly high cases of Epilepsy and MS in the UK, some 110,000 people living with MS in 2018; studies were spurred into the legalisation of Cannabis in […]
By Amber Smith Due to increasingly high cases of Epilepsy and MS in the UK, some 110,000 people living with MS in 2018; studies were spurred into the legalisation of Cannabis in […]
by Callum McFadzean Another Brexit extension date prolongs the anxiety for business in the UK. Pharmaceutical companies learned of a potential post-Brexit trade deal with the US that could boost the price […]
Recent Comments